Evaluation of anti phage CP51 effect of euphorbia myrcinites extract by a plaque reduction assay

Pharmacologyonline

Volumn 2, Issue , 2010, Pages 788-797

  Behravan, Javad ^a   Ramezani, Mohammad ^a   Alidoost, Hassan ^a   Gharaee, Melika Ehtesham ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anti phage; Antiviral activity; Euphorbia myrsinites; Plaque reduction assay

Indexed keywords

ANTIVIRUS AGENT; ASTRAGALIN; EUPHORBIA MYRCINITES EXTRACT; FLAVONOID GLYCOSIDE; KAEMPFEROL 3 ALPHA RHAMNOPYRANOSIDE; KAEMPFEROL 3 GALACTOSIDE; METHANOL; PLANT EXTRACT; TRIFLURIDINE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; BACILLUS CEREUS; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIOPHAGE; BACTERIUM CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFECT; DRUG SCREENING; DRUG STRUCTURE; EUPHORBIA; EUPHORBIA MYRCINITES; HOST CELL; IC 50; INCUBATION TIME; NONHUMAN; PHAGE CP51; PHYTOCHEMISTRY; PLAQUE REDUCTION ASSAY; VIRUS ATTACHMENT; VIRUS CULTURE; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 77957260990     PISSN: None     EISSN: 18278620     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Obi RK, Iroagba II, Ojiako OA. Virucidal potential of some edible Nigerian vegetables. African Journal of Biotechnology 2006; 5(19):1785-1788.
2. Jassim SAA, Naji MA. Novel antiviral agents: a medicinal plant perspective. Journal of Applied Microbiology 2003; 95(3):412-427.
3. Monavari HR, Hamkar R, Norooz-Babaei Z, et al. Antiviral effect assay of twenty five species of various medicinal plants families in Iran. IJMM 2007; 1(2):49-59.
4. Barla A, Öztürk M, Kültür S, Öksüz S. Screening of antioxidant activity of three Euphorbia species from Turkey. Fitoterapia 2007; 78(6):423-425.
5. Mucsi I, Molnar J, Hohmann J, Redei D. Cytotoxicities and anti-herpes simplex virus activities of diterpenes isolated from Euphorbia species. Planta Med 2001; 67(7):672-674.
6. Upadhyay RR, Sater AM, Moinzadeh F, et al. Tumor promoting activity of Euphorbia striatella (Boiss) and skin irritant activity of some Euphorbia species. Neoplasma 1984; 31(3):347-350.
7. Kinghorn AD, Evans FJ. A biological screen of selected species of the genus Euphorbia for skin irritant effects. Planta Med 1975; 28(4):326-335.
8. Eberle MM, Erb C, Flammer J, Meyer P. [Dermatitis and conjunctivitis after contact with Euphorbia myrsinites (wolf's milk extract)--a case report]. Klin Monatsbl Augenheilkd 1999; 215(3):203-204.
9. Abo KA. Characterisation of ingenol: an inflammatory diterpene from some Nigerian Euphorbia and Elaeophorbia species. Afr J Med Med Sci 1994; 23(2):161-163.
10. Duarte N, Kayser O, Abreu P, Ferreira MJU. Antileishmanial activity of piceatannol isolated from Euphorbia lagascae seeds. Phytotherapy Research 2007; 22(4):455-457.
11. Hohmann J, Molnar J, Redei D, et al. Discovery and biological evaluation of a new family of potent modulators of multidrug resistance: reversal of multidrug resistance of mouse lymphoma cells by new natural jatrophane diterpenoids isolated from euphorbia species. J Med Chem 2002; 45(12):2425-2431.
12. Akihisa T, Kithsiri Wijeratne EM, Tokuda H, et al. Eupha-7,9(11),24-trien-3beta-ol (antiquol C) and other triterpenes from Euphorbia antiquorum latex and their inhibitory effects on Epstein-Barr virus activation. J Nat Prod 2002; 65(2):158-162.
13. Semple SJ, Reynolds GD, O'Leary MC, Flower RL. Screening of Australian medicinal plants for antiviral activity. J Ethnopharmacol 1998; 60(2):163-172.
14. Yang CM, Cheng HY, Lin TC, Chiang LC, Lin CC. Euphorbia thymifolia suppresses herpes simplex virus-2 infection by directly inactivating virus infectivity. Clinical and Experimental Pharmacology and Physiology 2005; 32(5-6):346-349.
15. Khan MTH, Thompson KD, Ather A. Antiviral activities of three Bangladeshi medicinal plant extracts against herpes simplex viruses. Antiviral Research 2005; 67(2):107-119.
16. Dumkow K. [Flavonolglycosides from Euphorbia myrsinitis. Their isolation and identification. 6. Flavonoids of native Euphorbiacae]. Planta Med 1971; 19(3):197-202.
17. Aynehchi Y, Mojtabaii M, Yazdizadeh. Chemical examination of Euphorbia myrsinitis Linn. J Pharm Sci 1972; 61(2):292-293.
18. Rentzea M, Hecker E, Lotter H. New tetracyclic polyfunctional diterpenes from Euphorbia myrsinites L. crystal structure and stereochemistry of 14-deoxo-14b-hydroxymyrsinols. Tetrahedron Lett 1982; 23:1781-1784.
19. Öksüz S, Gürek F, Gil R.R, et al. Four diterpene esters from Euphorbia myrsinites. Phytochemistry 1995; 38:1457-1462.
20. Favrin SJ, Jassim SAA, Griffiths MW. Application of a novel immunomagnetic separationbacteriophage assay for the detection of Salmonella enteritidis and Escherichia coli O157: H7 in food. Int J Food Micribial 2003; 85:63-71.
21. Atta-ur-Rahman, Choudhary MI, Thomsen WJ. Bioassay Techniques for Drug Development. Harwood Academic Publishers: Australia 2001:47.
22. Madureira AM, Ascenso JR, Valdeira L, et al. Evaluation of the antiviral and antimicrobial activities of triterpenes isolated from Euphorbia segetalis. Nat. Prod. Res 2003; 17(5):375-380.
23. Cheng HY, Lin TC, Yang CM, et al. Putranjivain A from Euphorbia jolkini inhibits both virus entry and late stage replication of herpes simplex virus type 2 in vitro. J. Antimicrob. Chemother 2004; 53(4):577-583.
24. Beladi I, Pusztai R, Mucsi I, Bakay M, Gabor M. Activity of some flavonoids against viruses. Annuals of the New York Academy of Sciences 1997; 284:358-364.
25. Tsuchiya Y, Shimizu M, Hiyama Y, et al. Antiviral activity of natural occurring flavonoids in vitro. Chemical and Pharmaceutical Bulletin (Tokyo) 1985; 33:3881-3886.
26. Chen JL, Blanc P, Stoddart CA, et al. New iridoids from the medicinal plant Barleria prionitis with potent activity against respiratory syncytial virus. Journal of Natural Products 1998; 61:1295-1297.
27. Kernan MR, Amarquaye A, Chen JL, et al. Antiviral phenylpropanoid glycosides from the medicinal plant Markhamia lutea. Journal of Natural Products 1998; 61:564-570.
28. Li BQ, Fu T, Dongyan Y, Mikovits JA, Ruscetti FW, Wang JM. Flavonoid baicalin inhibits HIV-1 infection at the level of viral entry. Biochemical and Biophysical Research Communications 2000a; 276:534-538.
29. Lee JS, Kim HJ, Lee YS. A new Anti-HIV Flavonoid Glucuronide from Chrysanthemum morifolium. Planta Medica 2003; 69(9):859-861.
30. Mitrocotsa D, Mitaku S, Axarlis S, Harvala C, Malamas M. Evaluation of the antiviral activity of kaempferol and its glycosides against human cytomegalovirus. Planta Med 2000; 66(4):377-379.
31. Robin V, Irurzun A, Amoros M, Boustie J, Carrasco L. Antipoliovirus flavonoids from Psiadia dentate. Antiviral Chemistry and Chemotherapy 2001; 12(5):283-291.
32. Fesen MR, Pommier Y, Leteurtre F, et al. Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. Biochemical Pharmacology 1994; 48(3):595-608.
33. Kaul TN, Middleton Jr E, Ogra PL. Antiviral effect of flavonoids on human viruses. Journal of Medical virology 2005; 15(1):71-79.
34. O Subba Rao G, Sinsheimer JE, Cochran KW. Antiviral activity of triterpenoid saponins containing acylated beta-amyrin aglycones. J Pharm Sci 1974; 63(3):471-473.
35. Macías-Rubalcava ML, Hernández-Bautista BE, Jiménez-Estrada M, Cruz-Ortega R, Anaya AL. Pentacyclic Triterpenes with Selective Bioactivity from Sebastiania adenophora Leaves, Euphorbiaceae. J Chem Ecol 2007; 33:147-156.
36. Rabie A. Bioactivity of extracts and components of Pteleopsis myrtifolia. Ph.D. Thesis, University of Pretoria, South Africa 2005.
37. Bertin C, Weston LA, Huang T, et al. Grass roots chemistry: meta-Tyrosine, an herbicidal nonprotein amino acid. PNAS 2007; 104(43)16964-16969.